| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |